Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Takahisa, Sato"'
Autor:
Hideo Yoshida, Takamasa Ohki, Mineo Kanezaki, Takuma Teratani, Shinpei Sato, Shuntaro Obi, Takahisa Sato, Masatoshi Akamatsu, Koji Uchino, Hiroyoshi Taniguchi
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Platelet (PLT) transfusion was the most practical way to increase patients’ PLT counts before invasive hepatic procedures such as radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). A novel drug that raises the PLT
Externí odkaz:
https://doaj.org/article/4a7c05d198684aea80a2465f63aec9b7
Autor:
Takamasa Ohki, Koki Sato, Mayuko Kondo, Eriko Goto, Takahisa Sato, Yuji Kondo, Masatoshi Akamatsu, Shinpei Sato, Hideo Yoshida, Yukihiro Koike, Shuntaro Obi
Publikováno v:
Liver Research, Vol 4, Iss 4, Pp 199-205 (2020)
Background and aims: Lenvatinib (LEN) is a newly developed tyrosine kinase inhibitor, and is approved as a first-line treatment for advanced hepatocellular carcinoma (HCC) in Japan. This retrospective multi-center study investigated the effect of the
Externí odkaz:
https://doaj.org/article/49123965d8f046a6b238f35da0fd3112
Autor:
Takamasa Ohki, Koki Sato, Mayuko Kondo, Eriko Goto, Takahisa Sato, Yuji Kondo, Masatoshi Akamatsu, Shinpei Sato, Hideo Yoshida, Yukihiro Koike, Shuntaro Obi
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 2, Pp 141-149 (2020)
Abstract Background and Objective Experience of the use of lenvatinib (LEN) in the clinical setting remains limited. We conducted this study to elucidate the factors associated with progression-free survival (PFS) in patients with advanced HCC treate
Externí odkaz:
https://doaj.org/article/a0fbba4ad7974a68962730adec11987e
Autor:
Takashi Murakami, Hiroaki Shimizu, Kazuto Yamazaki, Hiroyuki Nojima, Akihiro Usui, Chihiro Kosugi, Kiyohiko Shuto, Shuntaro Obi, Takahisa Sato, Masato Yamazaki, Keiji Koda
Publikováno v:
World Journal of Clinical Cases. 10:8709-8717
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df4bc97392d5e95bf0ebfe06ae30fbe6
https://doi.org/10.12998/wjcc.v10.i24.8709
https://doi.org/10.12998/wjcc.v10.i24.8709
Autor:
Hideo Yoshida, Takamasa Ohki, Mineo Kanezaki, Takuma Teratani, Shinpei Sato, Shuntaro Obi, Takahisa Sato, Masatoshi Akamatsu, Koji Uchino, Hiroyoshi Taniguchi
Background Platelet (PLT) transfusion was the most practical way to increase patients’ PLT counts before invasive hepatic procedures such as radiofrequency ablation (RFA) for liver cancer. A novel drug that raises the PLT count by acting on the thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b289a443a10443329a49548bacf73c8
https://doi.org/10.21203/rs.3.rs-2423711/v1
https://doi.org/10.21203/rs.3.rs-2423711/v1
Publikováno v:
Progress in rehabilitation medicine. 7
The WISH-type S-form hip brace (WISH brace) has significantly improved hip function and functional mobility in patients with hip osteoarthritis (OA). However, most patients later undergo surgery. The main purpose of this study was to evaluate how lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76f93a6333d3877ddc2cf671db853c3
https://pubmed.ncbi.nlm.nih.gov/36337138
https://pubmed.ncbi.nlm.nih.gov/36337138
Autor:
Yuji Kondo, Eriko Goto, Mayuko Kondo, Masatoshi Akamatsu, Hideo Yoshida, Koki Sato, Yukihiro Koike, Takamasa Ohki, Shinpei Sato, Shuntaro Obi, Takahisa Sato
Publikováno v:
Liver Research, Vol 4, Iss 4, Pp 199-205 (2020)
Background and aims: Lenvatinib (LEN) is a newly developed tyrosine kinase inhibitor, and is approved as a first-line treatment for advanced hepatocellular carcinoma (HCC) in Japan. This retrospective multi-center study investigated the effect of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d80e5eec2334a9e8feb9558a10de7e3
https://doi.org/10.1016/j.livres.2020.09.002
https://doi.org/10.1016/j.livres.2020.09.002
Autor:
Koki Sato, Shuntaro Obi, Shinpei Sato, Yuji Kondo, Takamasa Ohki, Hideo Yoshida, Takahisa Sato, Masatoshi Akamatsu, Eriko Goto, Yukihiro Koike, Mayuko Kondo
Publikováno v:
Drugs-Real World Outcomes, Vol 7, Iss 2, Pp 141-149 (2020)
Drugs-Real World Outcomes
Drugs-Real World Outcomes
Background and Objective Experience of the use of lenvatinib (LEN) in the clinical setting remains limited. We conducted this study to elucidate the factors associated with progression-free survival (PFS) in patients with advanced HCC treated with LE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a9e2641f679623bb2992344ca697a2b
https://doaj.org/article/a0fbba4ad7974a68962730adec11987e
https://doaj.org/article/a0fbba4ad7974a68962730adec11987e
Autor:
Takahisa Sato, Klaus Marten, Helmut Greim, Noboru Shimizu, Takashi Ohara, Otto Dr Weiberg, Timothy D. Shaffer, Günter Dr. Prescher, Partha Nandi, Helmut Schwind
Publikováno v:
Ullmann's Encyclopedia of Industrial Chemistry
The article contains sections titled: 1. Acrylic Acid and Esters 1.1. Physical Properties 1.2. Chemical Properties 1.3. Production 1.3.1. Propene Oxidation 1.3.2. Esterification 1.4. Quality Specifications and Analysis 1.5. Storage and Transportation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68c4934ac352f4907d63f76b1ff48f83
https://doi.org/10.1002/14356007.a01_161.pub4
https://doi.org/10.1002/14356007.a01_161.pub4
Autor:
Ryota Masuzaki, Ryosuke Tateishi, Haruhiko Yoshida, Eriko Goto, Takahisa Sato, Takamasa Ohki, Tadashi Goto, Hideo Yoshida, Fumihiko Kanai, Yosuke Sugioka, Hitoshi Ikeda, Shuichiro Shiina, Takao Kawabe, Masao Omata
Publikováno v:
Canadian Journal of Gastroenterology, Vol 22, Iss 9, Pp 753-757 (2008)
BACKGROUND: Liver stiffness measurement (LSM) by transient elastography has recently been validated for the evaluation of liver fibrosis in chronic liver diseases. The present study focused on cases in which liver biopsy and LSM were discordant.
Externí odkaz:
https://doaj.org/article/3d060ec8bfab402a812ad24cdc6f98e5